Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge
Authors:
- C SkrabsCSC Skrabs
- C MüllerCMC Müller
- H AgisHAH Agis
- C MannhalterCMC Mannhalter
- U JägerUJU Jäger
- 30 August 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (9) , 1884-1886
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximabAmerican Journal of Hematology, 2001
- Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patientsCancer, 2001
- Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigenJournal of Gastroenterology, 2001
- Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case reportAnnals of Hematology, 2001
- Acute Hepatitis B in a Patient with Antibodies to Hepatitis B Surface Antigen Who Was Receiving RituximabNew England Journal of Medicine, 2001
- Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: A case report and review of the literatureAnnals of Oncology, 2001
- Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP ChemotherapyJournal of Clinical Oncology, 1999
- Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapyGastroenterology, 1991